Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2000 1
2011 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
Oosting SF, van der Veldt AAM, GeurtsvanKessel CH, Fehrmann RSN, van Binnendijk RS, Dingemans AC, Smit EF, Hiltermann TJN, den Hartog G, Jalving M, Westphal TT, Bhattacharya A, van der Heiden M, Rimmelzwaan GF, Kvistborg P, Blank CU, Koopmans MPG, Huckriede ALW, van Els CACM, Rots NY, van Baarle D, Haanen JBAG, de Vries EGE. Oosting SF, et al. Lancet Oncol. 2021 Dec;22(12):1681-1691. doi: 10.1016/S1470-2045(21)00574-X. Epub 2021 Nov 9. Lancet Oncol. 2021. PMID: 34767759 Free PMC article. Clinical Trial.
The SARS-CoV-2-binding antibody response in each patient cohort was non-inferior compared with cohort A. No new safety signals were observed. Grade 3 or worse serious adverse events occurred in no participants in cohort A, three (2%) of 137 patients in cohort B, six (2%) o …
The SARS-CoV-2-binding antibody response in each patient cohort was non-inferior compared with cohort A. No new safety signals were o …
VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma.
Kuczynski EA, Patten SG, Coomber BL. Kuczynski EA, et al. Oncology. 2011;81(2):126-34. doi: 10.1159/000332849. Epub 2011 Oct 6. Oncology. 2011. PMID: 21985798
METHODS: Expression patterns determined by immunohistochemistry for VEGFR2 and phosphorylated Smad2 in human gliomas were compared to overall survival, progression-free survival (PFS), initial versus recurrent tumors and tumor grade. ...
METHODS: Expression patterns determined by immunohistochemistry for VEGFR2 and phosphorylated Smad2 in human gliomas were compared to …
Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs.
Syrkin AB, Kiselev AV. Syrkin AB, et al. Oncology. 1980;37 Suppl 1:67-70. doi: 10.1159/000225499. Oncology. 1980. PMID: 6935578
The increased sensitivity to carminomycin was determined in dogs with spontaneous tumors (in 3 with osteosarcoma and 4 with hemablastoses) comparing with healthy animals. The therapeutic effect was not evaluated because of severe toxicity. ...
The increased sensitivity to carminomycin was determined in dogs with spontaneous tumors (in 3 with osteosarcoma and 4 with hemablastoses) …
A novel weekday-on/weekend-off UFT schedule.
Sadahiro S, Makuuchi H, Suzuki T, Tokunaga N, Ishizu K, Tajima T. Sadahiro S, et al. Oncology (Williston Park). 2000 Oct;14(10 Suppl 9):87-90. Oncology (Williston Park). 2000. PMID: 11098503
In a step toward a clinical trial, the tumor response and survival of a weekday-on/weekend-off schedule of UFT was compared with its conventional daily schedule in a cancer-bearing rat model. ...
In a step toward a clinical trial, the tumor response and survival of a weekday-on/weekend-off schedule of UFT was compared with its …
Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study.
Turtle L, Elliot S, Drake TM, Thorpe M, Khoury EG, Greenhalf W, Hardwick HE, Leeming G, Law A, Oosthuyzen W, Pius R, Shaw CA, Baillie JK, Openshaw PJM, Docherty AB, Semple MG, Harrison EM, Palmieri C; ISARIC4C Investigators. Turtle L, et al. Lancet Oncol. 2024 May;25(5):636-648. doi: 10.1016/S1470-2045(24)00107-4. Epub 2024 Apr 12. Lancet Oncol. 2024. PMID: 38621404 Free article.
METHODS: We conducted a prospective cohort study of patients aged older than 19 years and admitted to 306 health-care facilities in the UK with confirmed SARS-CoV-2 infection, who were enrolled in the International Severe Acute Respiratory and emerging Infections Consortium (ISAR …
METHODS: We conducted a prospective cohort study of patients aged older than 19 years and admitted to 306 health-care facilities in the UK w …